Hiber develops advanced tissue stabilization technology and infrastructure to enable biomedical research and long-term biological information preservation. We are building a platform for the rapid procurement, stabilization, and structured archiving of human tissue samples. By combining rapid donor access, controlled post-mortem intervals, and proprietary vitrification and cryopreservation technologies, Hiber provides research-grade human tissue with preserved structural and functional integrity. Our platform enables researchers to access high-quality human neural tissue samples, including vitrified neocortex slices, fresh tissue, snap-frozen samples, and region-specific biospecimens accompanied by detailed metadata. This transforms rare human samples into a scalable and schedulable translational research resource. At the same time, Hiber is building a new infrastructure around post-mortem biosampling. Through partnerships with funeral services, hospitals, and hospices, we establish rapid response procurement systems that allow medically supervised tissue sampling shortly after death. This enables three core applications: • Research-grade biospecimens for biomedical science • Biological information and medical reports for families • Long-term structural archiving of neural tissue Hiber operates at the intersection of biobanking, deep tech, and medicine, building the foundation for new forms of biomedical research and biological legacy.
| Website | https://hiber.org |
| Employees | 4 (2 on RocketReach) |
| Industry | Hospitals and Health Care |
Looking for a particular Hiber employee's phone or email?
Alexander German is the Co-Founder of Hiber.
2 people are employed at Hiber.